Trained and validated on data from 2,344 patients with smoldering multiple myeloma, a new algorithm using longitudinal biomarker dynamics provides accurate prediction of risk of disease progression, outperforming established models.
- Floris Chabrun
- Daniel E. Schwartz
- Irene M. Ghobrial
